Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 1/20 | 0.79 |
| ▸ | KDM1A | O60341 | 11/20 | 0.68 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.68 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.68 |
| ▸ | PRNP | P04156 | 1/20 | 0.68 |
| ▸ | TP53 | P04637 | 1/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.68 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.68 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.68 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.68 |
| ▸ | HTR1A | P08908 | 1/20 | 0.68 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.68 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.68 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.68 |
| ▸ | DRD2 | P14416 | 1/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.68 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.68 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28347553 | 0.91 | PIM1 (0.67) | PIM1KDM1ASIGMAR1SLC22A1PRNP | |
| SCHEMBL11402576 | 0.91 | PIM1 (0.67) | PIM1KDM1ASIGMAR1SLC22A1PRNP | |
| SCHEMBL29557345 | 0.91 | PIM1 (0.67) | PIM1KDM1ASIGMAR1SLC22A1PRNP | |
| SCHEMBL2784918 | 0.91 | PIM1 (0.67) | PIM1KDM1ASIGMAR1SLC22A1PRNP | |
| SCHEMBL16616978 | 0.91 | PIM1 (0.67) | PIM1KDM1ASIGMAR1SLC22A1PRNP | |
| SCHEMBL7397164 | 0.91 | PIM1 (0.67) | PIM1KDM1ASIGMAR1SLC22A1PRNP | |
| SCHEMBL30950675 | 0.91 | PIM1 (0.67) | PIM1KDM1ASIGMAR1SLC22A1PRNP | |
| SCHEMBL31302971 | 0.91 | PIM1 (0.67) | PIM1KDM1ASIGMAR1SLC22A1PRNP | |
| SCHEMBL342329 | 0.91 | PIM1 (0.67) | PIM1KDM1ASIGMAR1SLC22A1PRNP | |
| SCHEMBL4192605 | 0.91 | PIM1 (0.67) | PIM1KDM1ASIGMAR1SLC22A1PRNP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7445877-B2 | Charge transport materials having a central disulfane linkage | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-11-04 | — | — | US | claimed |
| US-7326506-B2 | Bridged charge transport materials having a central sulfur atom linkage | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-02-05 | — | — | US | claimed |
| EP-1600821-B1 | Bridged charge transport materials having a central sulfur atom linkage | SAMSUNG ELECTRONICS CO LTD (KR) | 2007-02-28 | — | — | EP | claimed |
| US-20050277038-A1 | Charge transport materials having a central disulfane linkage | S-PRINTING SOLUTION CO., LTD. (KR) | 2005-12-15 | — | — | US | claimed |
| US-20050266329-A1 | Bridged charge transport materials having a central sulfur atom linkage | S-PRINTING SOLUTION CO., LTD. (KR) | 2005-12-01 | — | — | US | claimed |
| EP-1600821-A1 | Bridged charge transport materials having a central sulfur atom linkage | Samsung Electronics Co., Ltd. (KR) | 2005-11-30 | — | — | EP | claimed |
| US-8193372-B2 | Phosphothiophene and phosphothiazole HCV polymerase inhibitors | IDENIX PHARMACEUTICALS, INC. (US) | 2012-06-05 | — | — | US | disclosed |
| EP-2403860-A2 | PHOSPHOTHIOPHENE AND PHOSPHOTHIAZOLE AS HCV POLYMERASE INHIBITORS | IDENIX Pharmaceuticals, Inc. (US) | 2012-01-11 | — | — | EP | disclosed |
| US-8088785-B2 | Therapeutic compound and treatments | MEDISYN TECHNOLOGIES, INC. (US) | 2012-01-03 | — | — | US | disclosed |
| US-20100233123-A1 | PHOSPHOTHIOPHENE AND PHOSPHOTHIAZOLE HCV POLYMERASE INHIBITORS | IDENIX PHARMACEUTICALS, INC. (US) | 2010-09-16 | — | — | US | disclosed |
| WO-2010101967-A2 | PHOSPHOTHIOPHENE AND PHOSPHOTHIAZOLE HCV POLYMERASE INHIBITORS | IDENIX PHARMACEUTICALS, INC. (US) | 2010-09-10 | — | — | WO | disclosed |
| US-20100137253-A1 | THERAPEUTIC COMPOUND AND TREATMENTS | MEDISYN TECHNOLOGIES, INC. (US) | 2010-06-03 | — | — | US | disclosed |
| US-7652029-B2 | Therapeutic compound and treatments | MEDISYN TECHNOLOGIES, INC. (US) | 2010-01-26 | — | — | US | disclosed |
| EP-1465020-A2 | Organophotoreceptor with a charge transport compound having an epoxy group | Samsung Electronics Co., Ltd. (KR) | 2004-10-06 | — | — | EP | disclosed |
| US-20040191655-A1 | Polymeric charge transport compositions | S-PRINTING SOLUTION CO., LTD. (KR) | 2004-09-30 | — | — | US | disclosed |
| US-20040170910-A1 | Organophotoreceptor with a charge transport material having two hydrazone groups | S-PRINTING SOLUTION CO., LTD. (KR) | 2004-09-02 | — | — | US | disclosed |
| US-20040170909-A1 | Organophotoreceptor with a charge transport material having two (9-fluorenylidene) malononitrile groups | S-PRINTING SOLUTION CO., LTD. (KR) | 2004-09-02 | — | — | US | disclosed |
| EP-1452924-A1 | Organophotoreceptor with charge transport material having two hydrazone groups | Samsung Electronics Co., Ltd. (KR) | 2004-09-01 | — | — | EP | disclosed |
| EP-1452925-A1 | Organophotoreceptor with a charge transport material having two (9-fluorenylidene) malononitrile groups | Samsung Electronics Co., Ltd. (KR) | 2004-09-01 | — | — | EP | disclosed |
| US-20040161685-A1 | Organophotoreceptor with a charge transport compound having an epoxy group | S-PRINTING SOLUTION CO., LTD. (KR) | 2004-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040170909-A1 | Organophotoreceptor with a charge transport material having two (9-fluorenylidene) malononitrile groups | SLC39A14, SLC37A4, SLC39A7 | PIM1 4264/4885KDM1A 3470/4885SIGMAR1 892/4885 |
| US-20040170910-A1 | Organophotoreceptor with a charge transport material having two hydrazone groups | SLC16A7, SLC43A1, SLC16A8 | PIM1 4621/4885KDM1A 3033/4885SIGMAR1 1022/4885 |
| US-20100137253-A1 | THERAPEUTIC COMPOUND AND TREATMENTS | MDH1, MDH2, MBOAT7 | PIM1 4242/4885KDM1A 4853/4885SIGMAR1 4083/4885 |
| US-20050266329-A1 | Bridged charge transport materials having a central sulfur atom linkage | NR2E3, NR4A2, NR2C2 | PIM1 4644/4885KDM1A 3378/4885SIGMAR1 1117/4885 |
| US-20100233123-A1 | PHOSPHOTHIOPHENE AND PHOSPHOTHIAZOLE HCV POLYMERASE INHIBITORS | PPP3CB, POLR2E, PSAT1 | PIM1 1981/4885KDM1A 4243/4885SIGMAR1 1381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.